HYPERGLYCEMIA AND ACUTE CORONARY SYNDROME


A.I. Martynov, E.V. Akatova, O.P. Nikolin, I.V. Urlaeva

Department of Hospital Therapy №1 SBEI HPE MSMSUn.a. A.I. Evdokimov of RMPH, Moscow
The article discusses the problem of the relationship between blood glucose levels and outcomes of acute coronary syndrome (ACS). Over the past decade, data on the adverse effects of hyperglycemia on the course and prognosis of ACS have been accumulated. It has been established that elevated blood glucose levels on admission are associated with high mortality both during inpatient treatment and during the first year after a heart attack regardless of the history of diabetes mellitus. ACS patients with elevated blood glucose levels should be considered as high risk group for cardiovascular complications. This is necessary not only in connection with a worse prognosis, typical for this group of patients, but also for selection of patients in need for extra attention, priority use of aggressive techniques, and use of additional methods of treatment.

Literature


  1. Deedwania P., Kosiborod M., Barrett E., Ceriello A., Isley W., Mazzone T., Raskin P. American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Hyperglycemia and Acute Coronary Syndrome. A Scientific Statement From the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity and Metabolism. Circulation. 2008;117:1610–19.
  2. Ceriello A. Cardiovascular effects of acute hyperglycaemia: pathophysiological underpinnings. Diab. Vasc. Dis. Res. 2008;5(4):260–68.
  3. Lavi S., Kapeliovich M., Gruberg L., Roguin A., Boulos M., Grenadier E., Amikam S., Markiewicz W., Beyar R., Hammerman H. Hyperglycemia during acute myocardial infarction in patients who are treated by primary percutaneous coronary intervention: impact on long-term prognosis. Int. J. Cardiol. 2008;123:117–22.
  4. Fuentes B., Castillo J., San Jose B., Leira R., Serena J., Vivancos J., Davalos A., Nunez A.G., Egido J., Diez-Tejedor E. Stroke Project of the Cerebrovascular Diseases Study Group, Spanish Society of Neurology. The Prognostic Value of Capillary Glucose Levels in Acute Stroke The GLycemia in Acute Stroke (GLIAS) Study. Stroke. 2009;40:562–68.
  5. Dutawa A., Buldak L.., Krysiak R., Okopien B. Hormonal supplementation in endocrine dysfunction in critically ill patients. Pharmacol. Rep. 2007;59:139–49.
  6. Zeymer U. Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes. Int. J. Cardiol. 2006;107:11–20.
  7. Ryden L., Standl E., Bartnik M., Van den Berghe G., Betteridge J., de Boer M.J., Cosentino F., Jönsson B., Laakso M., Malmberg K., Priori S., Ostergren J., Tuomilehto J., Thrainsdottir I., Vanhorebeek I., Stramba-Badiale M., Lindgren P., Qiao Q., Priori S.G., Blanc J.J., Budaj A., Camm J., Dean V., Deckers J., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., Tamargo J., Zamorano J.L., Deckers J.W., Bert-rand M., Charbonnel B., Erdmann E., Ferrannini E., Flyvbjerg A., Gohlke H., Juanatey J.R., Graham I., Monteiro P.F., Parhofer K., Pyörala K., Raz I., Schernthaner G., Volpe M., Wood D.; Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD).Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur. Heart J. 2007;28:88–136.
  8. Asadollahi K., Beeching N., Gill G. Hyperglycaemia and mortality. J. R. Soc. Med. 2007;100(11):503–07.
  9. Bakker W., Eringa E.C., Sipkema P., van Hinsbergh V.W. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res. 2009;335:165–89.
  10. Ishihara M., Inoue I., Kawagoe T., Shimatani Y., Kurisu S., Nishioka K., Umemura T., Nakamura S., Yoshida M. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am. Heart. J. 2003;146:674–78.
  11. Timmer J.R., Ottervanger J.P., de Boer M.J., Dambrink J.H., Hoorntje J.C., Gosselink A.T., Suryapranata H., Zijlstra F., van ‘t Hof A.W.; Zwolle Myocardial Infarction Study Group. Hyperglycemia Is an Important Predictor of Impaired Coronary Flow Before Reperfusion Therapy in ST-Segment Elevation Myocardial Infarction. J. Am. Coll. Cardiol. 2005;45:999–1002.
  12. Undas A., Wiek I., Stepien E., Zmudka K., Tracz W. Hyperglycemia is Associated with Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients with Acute Coronary Syndrome. Diabetes Care. 2008;31(8):1590–95.
  13. Bianchi C., Miccoli R., Penno G., Del Prato S. Primary Prevention of Cardiovascular Disease in People With Dysglycemia. Diabetes Care. 2008;31(2):208–14.
  14. Mudespacher D., Radovanovic D., Camenzind E., Essig M., Bertel O., Erne P, Eberli FR, Gutzwiller F. Amis Plus Investigators. Admission glycaemia and outcome in patients with acute coronary syndrome. Diab. Vasc. Dis.Res. 2007;4(4):346–52.
  15. Abadal A.C., Flores J.S. The Significance of Hyperglycemia in Acute Coronary Syndrome. Rev. Esp. Cardiol. 2008;61(5):447–50.
  16. Zeller M., Verges B., L’Huillier I., Brun J.M. Cottin Y. Glycemia in acute coronary syndromes. Diabetes Metab. 2006;32(2):2S42–47.
  17. Deedwania P., Kosiborod M., Barrett E., Ceriello A., Isley W., Mazzone T., Raskin P. American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Hyperglycemia and Acute Coronary Syndrome: A Scientific Statement From the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2008;117:1610–19.
  18. Vivas D., Garcia-Rubira J.C., Gonzalez-Ferrer J.J., Nunez-Gil I., del Prado N, Fernandez-Ortiz A., Macaya C.. Prognostic Value of First Fasting Glucose Measurement Compared With Admission Glucose Level in Patients With Acute Coronary Syndrome. Rev. Esp. Cardiol. 2008;61(5):458–64.
  19. Saleem T., Mohammad K.H., Abdel-Fattah M.M. Association of glycosylated haemoglobin level and diabetes mellitus duration with the severity of coronary artery disease. Dis. Res. 2008;5:184–89.


About the Autors


A.I. Martynov - Acad. of RAS, Doctor of Medical Sciences, Prof. at the Department of Hospital Therapy № 1 SBEI HPE MSMSU n.a. A.E. Evdokimov of RMPH, Moscow
E.V. Akatova - Doctor of Medical Sciences, Prof. at the Department of Hospital Therapy № 1 SBEI HPE MSMSU n.a. A.E. Evdokimov of RMPH, Moscow; e-mail: akev@list.ru
O.P. Nikolin – PhD in Medical Sciences, Teaching Assistant Department of Hospital Therapy № 1 SBEI HPE MSMSU n.a. A.E. Evdokimov of RMPH, Moscow
I.V. Urlaeva - Teaching Assistant Department of Hospital Therapy № 1 SBEI HPE MSMSU n.a. A.E. Evdokimov of RMPH, Moscow


Similar Articles


Бионика Медиа